Tur'an, Israel

Taher Nassar

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taher Nassar. Retrieved from https://idiyas.com/inventor/taher-nassar-qo09n8c4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Taher Nassar

Introduction

Taher Nassar is an accomplished inventor based in Tur'an, Israel. He has made significant contributions to the field of cytotoxic compositions, particularly through his innovative patent related to taxol derivatives.

Latest Patents

Taher Nassar holds a patent for "Derivatives of taxol and closely related compounds." This patent describes a cytotoxic composition in which two moieties are covalently conjugated. The first moiety is a tax moiety, selected from taxanes, taxane derivatives, and other closely related compounds. The second moiety is an acid moiety, chosen from lipoic acid, acetylcysteine, and compounds having an acidic group. This innovative approach has the potential to enhance the efficacy of treatments involving taxol derivatives.

Career Highlights

Throughout his career, Taher Nassar has focused on developing novel compounds that can improve therapeutic outcomes. His work has been recognized for its potential impact on cancer treatment, showcasing his dedication to advancing medical science.

Collaborations

Taher Nassar has collaborated with fellow inventor Anwar Rayan, contributing to the development of innovative solutions in their field. Their partnership exemplifies the importance of teamwork in driving forward scientific advancements.

Conclusion

Taher Nassar's contributions to the field of cytotoxic compositions highlight his innovative spirit and commitment to improving healthcare. His patent on taxol derivatives represents a significant step forward in cancer treatment research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…